Author: Jane Edwards|| Date Published: December 28, 2016
Four companies have won spots on a potential 10-year, $159 million contract to provide preclinical drug development support services for the National Institute of Allergy and Infectious Diseases.
The multiple-award, indefinite-delivery/indefinite-quantity contract covers the development of manufacturing processes and analytical test procedures, regulatory services, manufacturing and product characterization in support of the development of biopharmaceutical drug candidates for infectious diseases, the National Institutes of Health said in a FedBizOpps notice.
Former NASA executive Dan Tenney has been selected to succeed Michael Williamson as senior vice president of global business development and strategy at Lockheed…
bachelor’s”Brandy Durham has taken on new responsibilities as chief data and artificial intelligence officer at ManTech. The Herndon, Virginia-based company…
Four companies have won spots on a potential 10-year, $159 million contract to provide preclinical drug development support services for the National Institute of Allergy and Infectious Diseases.
